Insufficient Data
Stock has not been able to generate better return on equity than bank FD
Stock doesn't offer attractive dividend returns
Good time to consider, as stock is not in overbought zone
Stock not in ASM/GSM lists and not a lot of promoter holding is pledged
—
—
—
Bafna Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged in the manufacture of drugs and medicines.
Customise key metrics, see detailed forecasts, download stock data and more
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
Bafna Pharmaceuticals Limited has informed the Exchange about Closure of trading window from 1st day of July 2022 till the end of Forty-Eight (48) hours after the declaration of unaudited Financial Results of the Company for the quarter ending 30th June 2022 | Download
Bafna Pharmaceuticals Limited has informed the Exchange about Closure of trading window from 1st day of July 2022 till the end of Forty-Eight (48) hours after the declaration of unaudited Financial Results of the Company for the quarter ending 30th June 2022 | Download
Final • Div/Share: ₹ 0.6
Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Insufficient Data